Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Generating natural killer cells for adoptive transfer: expanding horizons
Soumyadipta Kundu, Mark E. Gurney, Michael O’Dwyer
Cytotherapy (2021) Vol. 23, Iss. 7, pp. 559-566
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Augmenting NK cell-based immunotherapy by targeting mitochondrial apoptosis
Rongqing Pan, Jeremy Ryan, Deng Pan, et al.
Cell (2022) Vol. 185, Iss. 9, pp. 1521-1538.e18
Open Access | Times Cited: 131
Current Perspectives on “Off-The-Shelf” Allogeneic NK and CAR-NK Cell Therapies
Erica L. Heipertz, Evan R. Zynda, Tor Espen Stav-Noraas, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 125
Next-Generation CAR T-cell Therapies
Regina M. Young, Nils W. Engel, Uğur Uslu, et al.
Cancer Discovery (2022) Vol. 12, Iss. 7, pp. 1625-1633
Open Access | Times Cited: 123
The NK-92 cell line—30 years later: its impact on natural killer cell research and treatment of cancer
Hans Klingemann
Cytotherapy (2023) Vol. 25, Iss. 5, pp. 451-457
Open Access | Times Cited: 63
Chimeric antigen receptor- and natural killer cell receptor-engineered innate killer cells in cancer immunotherapy
Cai Zhang, Yuan Hu, Weihua Xiao, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 9, pp. 2083-2100
Open Access | Times Cited: 69
Emerging NK cell therapies for cancer and the promise of next generation engineering of iPSC-derived NK cells
Sainiteesh Maddineni, John L. Silberstein, John B. Sunwoo
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 5, pp. e004693-e004693
Open Access | Times Cited: 49
From CD16a Biology to Antibody-Dependent Cell-Mediated Cytotoxicity Improvement
Loïs Coënon, Martín Villalba
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 46
Adoptive Cell Therapy for Nonhematologic Solid Tumors
Daniel J. Olson, Kunle Odunsi
Journal of Clinical Oncology (2023) Vol. 41, Iss. 18, pp. 3397-3407
Closed Access | Times Cited: 25
Natural killer cell-derived exosomes for cancer immunotherapy: innovative therapeutics art
Zahra Hatami, Zahra Sadat Hashemi, Mohamad Eftekhary, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 22
Chimeric antigen receptor-engineered NK cells: new weapons of cancer immunotherapy with great potential
Xiao Wang, Xuejiao Yang, Xiang Yuan, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 35
Innovative Strategies to Improve the Clinical Application of NK Cell-Based Immunotherapy
Mubin Tarannum, Rizwan Romee, Roman M. Shapiro
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 33
Feeder Cells at the Interface of Natural Killer Cell Activation, Expansion and Gene Editing
Mark E. Gurney, Soumyadipta Kundu, Shubham Pandey, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 29
The therapeutic potential of immune cell-derived exosomes as an alternative to adoptive cell transfer
Yeonsun Hong, In‐San Kim
BMB Reports (2022) Vol. 55, Iss. 1, pp. 39-47
Open Access | Times Cited: 28
Successful targeting of PD-1/PD-L1 with chimeric antigen receptor-natural killer cells and nivolumab in a humanized mouse cancer model
Wai Nam Liu, Wing Yan So, Sarah Harden, et al.
Science Advances (2022) Vol. 8, Iss. 47
Open Access | Times Cited: 26
NK Cell-Based Immunotherapy in Colorectal Cancer
Mariella Della Chiesa, Chiara Setti, Chiara Giordano, et al.
Vaccines (2022) Vol. 10, Iss. 7, pp. 1033-1033
Open Access | Times Cited: 25
Engineered NK Cells Against Cancer and Their Potential Applications Beyond
Maria Karvouni, Marcos Vidal-Manrique, Andreas Lundqvist, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 22
The application of autologous cancer immunotherapies in the age of memory-NK cells
Gaby D. Lizana‐Vasquez, Madeline Torres‐Lugo, R. Brent Dixon, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy
Loredana Cifaldi, Ombretta Melaiu, Roberto Giovannoni, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
The key role of immunomodulatory cytokines for the development of novel NK cell-based cancer therapies
A.A. Câmara, Diego Barriales, Ainara Azueta Etxebarría, et al.
International review of cell and molecular biology (2025)
Closed Access
The Current State of Cytotherapy and the Field of Cell and Gene Therapy
William Ying Khee Hwang, Ezzah Mohamed Muzammil
Cytotherapy (2025)
Closed Access
Novel gene manipulation approaches to unlock the existing bottlenecks of CAR-NK cell therapy
Fatemeh Dehghan, Yekta Metanat, Mandana Askarizadeh, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access
Efficient Large-Scale Expansion of Cord Blood-Derived NK Cells: Leveraging Lipopolysaccharide for Enhanced NK Cell production
Hataiwan Kunkanjanawan, Sirilak Somredngan, Tanut Kunkanjanawan, et al.
Cytotherapy (2025)
Closed Access
Protocol for isolation and expansion of natural killer cells from human peripheral blood scalable for clinical applications
Soumyadipta Kundu, Leonie Durkan, Michael O’Dwyer, et al.
Biology Methods and Protocols (2025) Vol. 10, Iss. 1
Open Access
Therapeutic effects of NK cell-derived EVs on cancer: Current advances and future treatment strategies
Mehtap Kızılpınar, Mohammadreza Dastourı
(2025) Vol. 2, Iss. 1, pp. 10-24
Closed Access
Combining adoptive NK cell infusion with a dopamine-releasing peptide reduces senescent cells in aged mice
Zongke Bai, Peiwei Yang, Yu Fan, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 4
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top